Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1-2
pubmed:dateCreated
2005-9-16
pubmed:abstractText
The anticarcinogenic capacity of interferon (IFN) was assessed in a cohort of Japanese patients with chronic hepatitis C en masse.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0300-5526
pubmed:author
pubmed:copyrightInfo
Copyright (c) 2006 S. Karger AG, Basel.
pubmed:issnType
Print
pubmed:volume
49
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
82-90
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:16166794-Adolescent, pubmed-meshheading:16166794-Adult, pubmed-meshheading:16166794-Aged, pubmed-meshheading:16166794-Antiviral Agents, pubmed-meshheading:16166794-Carcinoma, Hepatocellular, pubmed-meshheading:16166794-Cohort Studies, pubmed-meshheading:16166794-Female, pubmed-meshheading:16166794-Hepatitis C, Chronic, pubmed-meshheading:16166794-Humans, pubmed-meshheading:16166794-Interferon Type I, pubmed-meshheading:16166794-Interferon-beta, pubmed-meshheading:16166794-Japan, pubmed-meshheading:16166794-Liver Neoplasms, pubmed-meshheading:16166794-Male, pubmed-meshheading:16166794-Middle Aged, pubmed-meshheading:16166794-Multivariate Analysis, pubmed-meshheading:16166794-Recombinant Proteins, pubmed-meshheading:16166794-Retrospective Studies, pubmed-meshheading:16166794-Treatment Outcome
pubmed:year
2006
pubmed:articleTitle
Anticarcinogenic impact of interferon on patients with chronic hepatitis C: a large-scale long-term study in a single center.
pubmed:affiliation
Department of Gastroenterology, Toranomon Hospital, Toranomon 2-2-2, Minato-ku, Tokyo 105-8470, Japan. ikedakenji@tora.email.ne.jp
pubmed:publicationType
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't